This Overlooked Pipeline Stock Could Be a Generational Wealth Builder for Patient Investors

Hess Midstream (HESM) has fallen 20% following Chevron's announcement to divest its stake, but analysts argue the market overreacted. Despite lower fees from Chevron in the Bakken Shale through 2033, the company offers a 10% dividend yield and benefits from a 40% reduction in share count, positioning it as a potential long-term wealth builder for patient investors.